Life Beyond Trauma: 1-on-1 e-Health Program for Parents of Neurodiverse Children

Sponsor
IWK Health Centre (Other)
Overall Status
Completed
CT.gov ID
NCT04385927
Collaborator
Canadian Institutes of Health Research (CIHR) (Other), Child-Bright Network (Other)
66
1
2
18.1
3.7

Study Details

Study Description

Brief Summary

Parents of neurodiverse children are more likely to experience traumatic events related to the care of their child/children. This increases the probability to experience Posttraumatic Stress Injury (PTSI). However, interventions addressing PTSI symptoms in parents are rare.

In this research project the study investigators will test the feasibility and efficacy of e-NET, a distance-delivered, exposure-based intervention for PTSI adapted to the needs of parents of neurodiverse children. E-NET is an adapted version of the Narrative Exposure Therapy (NET), an evidence-based intervention approach for individuals with PTSI who have experienced repeated or continuous trauma. The intervention will be conducted via videoconferencing with trained paraprofessionals. During the intervention a narrative of both positive and negative (traumatic) experiences in the parents' life will be created. The intervention contains approx. 12 one-on-one sessions with a trained paraprofessional via videoconferencing.

The study design is a waitlist control group design. Approx. 20 participants will receive e-NET directly after the baseline survey and 20 participants will receive e-NET approx. 3 months after the baseline survey. To test the efficacy of the intervention, participants will fill out surveys about PTSI and other mental health symptoms before, directly after, and 2 and 6 months after the intervention. Adverse events and distress will be assessed in every session. As part of the baseline, participants will complete the survey "Surviving and Thriving in Parenting Neurodiverse Children" to determine their eligibility for the intervention. Main eligibility criterion is the presence of PTSI symptoms.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: e-Net for Parents of Neurodiverse Children
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Life Beyond Trauma: 1-on-1 e-Health Program for Parents of Neurodiverse Children
Actual Study Start Date :
Jun 29, 2020
Actual Primary Completion Date :
Aug 31, 2021
Actual Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Immediate e-NET Group

Parents of neurodiverse children with PTSI will receive e-NET immediately after the baseline survey

Behavioral: e-Net for Parents of Neurodiverse Children
One-on-one distance coached intervention; approx. 12 sessions at 60-90 minutes.

Experimental: Wait List Control Group

Parents of neurodiverse children with PTSI will receive e-NET 3 months after the baseline survey

Behavioral: e-Net for Parents of Neurodiverse Children
One-on-one distance coached intervention; approx. 12 sessions at 60-90 minutes.

Outcome Measures

Primary Outcome Measures

  1. Change in PTSI symptoms [Baseline, Immediately Post- intervention, 2 months post-intervention, 6 months post-intervention]

    PTSD symptoms are measured with the PTSD Checklist - 5 (PCL-5). Respondents are asked to rate how bothered they have been by each of 20 items in the past month on a 5- point Likert scale ranging from 0-4. Items are summed to provide a total severity score. Higher scores indicate a worse outcome

Secondary Outcome Measures

  1. Change in Overall Health [Baseline, Wait-list Baseline; through study completion, an average of 12 weeks; Immediately Post-assessment; 2 month follow up; 6 month follow up]

    General health will be measured with the questionnaire PROMIS Global Health Caregiver's general health

  2. Change in Depression Symptoms [Baseline, Immediately Post-assessment, 2 month follow up, 6 month follow up]

    Depression symptoms will be measured with the Patient Health Questionnaire (PHQ-9)

  3. Change in overall functionality [Baseline; Wait list Baseline, Immediately Post intervention; 2 month follow up; 6 month follow up]

    Functionality will be measured with the Sheehan Disability Scale (SDS). SDS is measured on a 10-point scale (0-9). Higher score indicates a worse outcome.

  4. Posttraumatic Growth [Baeline; Wait list Baseline; Immediately Post intervention; 2 month follow up; 6 month follow up]

    Posttraumatic growth will be measures using the Posttraumatic Growth Inventory - Short Form (PTGI ). The PTGI is measured on a 6-point Likert scale (score 0-5). Higher score indicates a better outcome.

  5. Parent-child Relationship [Baseline; Wait list Baseline; Immediately Post intervention; 2 month follow up; 6 month follow up]

    The parent-child relationship will be measured with the Parent and Family Adjustment Scales (PAFAS). Items are rated from 0 to 3. Note that shaded items in the scoring key below must be reverse scored (i.e. 0=3, 1=2, 2=1, 3=0) before summing the Total Score. High scores indicate worse outcome.

  6. Satisfaction with Lifeline Tool [During week 1 of intervention]

    The satisfaction with Lifeline Tool (self-constructed) will be measured with a self-constructed 3-item usability questionnaire. It is scored on a five point scale. Items are rated from 0-4. Higher score indicates better outcome.

  7. Change in Anxiety Symptoms [Baseline, Immediately Post-assessment, 2 month follow up, 6 month follow up]

    Anxiety Symptoms are measured with the Generalized Anxiety Disorder (GAD-7). Items are scored on a four point scale, items are rated from 0-3. Higher score indicates better outcome.

  8. Change in Physical Health Symptoms [Baseline; throughout study completion, approximately 12 week; Immediately Post-assessment; 2 month follow up; 6 month follow up]

    Physical Health symptoms will be assessed with the Patient Health Questionnaire Physical Symptoms (PHQ-15). Items are scored on a three point scale, items are rated from 0-2. Higher score indicates worse outcome.

  9. Adverse Events [throughout study completion, approximately 12 weeks; immediately post intervention]

    Adverse events will be assessed with a self-constructed questionnaire for adverse events, the course of symptoms during intervention and general distress.

  10. Therapeutic Alliance [Immediately post intervention]

    The interaction between coach and client will be assessed through the Therapeutic Alliance- Working Alliance Inventory - Short Form Revised (WAI-SR)

  11. Participant Satisfaction [Immediately Post intervention]

    Client satisfaction will be assessed with the Client Satisfaction Questionnaire (CSQ-8) and some additional (self-constructed) qualitative questions. CAQ-8 Items are scored on a four point scale, items are rated from 0-3. Higher score indicates worse outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Inclusion Criteria: Parent/Caregivers must meet the following criteria to be eligible to move on to Consent

  1. Be a parent/caregiver of a neurodiverse child

  2. Be at least 18 years of age

  3. Be able to understand spoken and written English at a Grade 8 level

  4. Fulfill the criteria of full or subclinical PTSI according to DSM-5, measured with the Life Events Checklist for DSM-5, the Parent Trauma Checklist and the PTSD Checklist for DSM-5. For this they have to report at least one traumatic event in the LEC-5 or the Stressful Life Experiences of Parents Checklist. To fulfill all PTSI criteria, the participant additionally needs to respond with "moderately" or higher in at least one item for the criteria B and C and two items for criteria D and E. Subclinical PTSI is fulfilled if the participant meets all but one criterion of B, C, D, or E is not met.

  5. Have access to a computer with high speed Internet

  6. Live in Canada

  7. Commit to the requirements of taking part in the study (12 weekly coaching calls)

Exclusion Criteria:
  1. Acute suicidal behavior or other extreme forms of self-destructive behavior

  2. Moderate to severe symptoms of dissociation

  3. Acute psychotic symptoms

  4. Previously participated in exposure intervention for PTSI/PTSD

Contacts and Locations

Locations

Site City State Country Postal Code
1 IWK Health Centre Halifax Nova Scotia Canada B3K6R8

Sponsors and Collaborators

  • IWK Health Centre
  • Canadian Institutes of Health Research (CIHR)
  • Child-Bright Network

Investigators

  • Principal Investigator: Patrick McGrath, PhD, IWK Health Centre
  • Principal Investigator: Elisa Kaltenbach, PhD, IWK Health Centre

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Patrick J. McGrath, Principal Investigator, IWK Health Centre
ClinicalTrials.gov Identifier:
NCT04385927
Other Study ID Numbers:
  • 23865
First Posted:
May 13, 2020
Last Update Posted:
Mar 31, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2022